Forte Biosciences, Inc. Stock Performance

Open N/A	Prev. Close N/A	Circuit Range N/A
Day Range N/A	Year Range N/A	Volume N/A
Average Traded N/A

Forte Biosciences, Inc. Share Price Chart

$0.00$0.00

Forte Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap N/A	PE Ratio (TTM) N/A	Dividend Yield 0.00%
EPS (TTM) $-4.14	Revenue (TTM) $0.00	Return On Equity (TTM) -47.85%
Profit Margin N/A	Debt to Equity 0.00	Quarterly Earnings Growth YoY -31.96%

Forte Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$0.00	$0.00	$0.00	$0.00
Net Profit	-$17.68	-$24.79	-$22.14	-$23.33
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	-40.21%	10.69%	-5.37%

Forte Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$0.00	$0.00	$0.00	$0.00
Net Profit	-$13.88	-$31.48	-$35.48	-$69.38
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	-126.80%	-12.71%	-95.55%

About Forte Biosciences, Inc.

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

Forte Biosciences, Inc. Historical Returns

Month	Open	Close	Change %

FBRX Share Price FAQs

What is Forte Biosciences, Inc. share price today?

Forte Biosciences, Inc. share price today is $0.00 as on October 9, 2026 at 7:18 am IST.

What is the 52 week high and 52 week low of Forte Biosciences, Inc. stock?

52 week high/low data for Forte Biosciences, Inc. is currently unavailable.

What is FBRX's net income for the last quarter?

FBRX's net income for the last quarter is -23.33B USD.

Can I buy FBRX shares in India?

Yes. You can buy FBRX in India by opening an international trading account.